FIBROBIOLOGICS INC (FBLG)
US31573L1052 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||||
| Net Income | -17.78M | -16.48M | -5.12M | -1.58M | |||
| Depreciation Amortization | 141.00K | 47.00K | N/A | N/A | |||
| Change In Working Capital | 1.16M | 493.00K | 307.00K | 172.00K | |||
| Interest Paid | 15.00K | 2.00K | 0.00 | 0.00 | |||
| Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 6.05M | 9.54M | 748.00K | N/A | |||
| OPERATING CASH FLOW | -10.43M | -6.40M | -4.07M | -1.41M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||||
| Capital Expenditure | -87.00K | -495.00K | N/A | N/A | |||
| INVESTING CASH FLOW | -87.00K | -495.00K | N/A | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||||
| Debt Issued/Reduced | 115.00K | 300.00K | 3.77M | 1.52M | |||
| Stock Issued/Repurchased | 7.46M | 16.14M | 2.15M | N/A | |||
| Other Financing Activity | N/A | -2.65M | N/A | 292.00K | |||
| FINANCING CASH FLOW | 7.58M | 13.79M | 5.92M | 1.82M | |||
| CHANGE IN CASH | -2.94M | 6.90M | 1.86M | 407.00K | |||
| FREE CASH FLOW | |||||||
| Operating Cash Flow | -10.43M | -6.40M | -4.07M | -1.41M | |||
| Capital Expenditure | -87.00K | -495.00K | N/A | N/A | |||
| FREE CASH FLOW | -10.52M | -6.90M | -4.07M | -1.41M | |||
All data in USD